GREENLAND MINES LTD Accounts Payable
GREENLAND MINES LTD (GRML) had Accounts Payable of $698.22 thousand as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-17
- 2026-06-30: Accounts Payable, Current $698.22K.
- 2026-03-31: Accounts Payable, Current $151.11K.
- 2025-12-31: Accounts Payable, Current $44.61K.
- 2025-09-30: Accounts Payable, Current $34.91K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $698.22K 10-Q · filed 2026-08-17 |
| 2026-03-31 | $151.11K 10-Q/A · filed 2026-08-14 |
| 2025-12-31 | $44.61K 10-Q · filed 2026-08-17 |
| 2025-09-30 | $34.91K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $12.63K 10-Q · filed 2025-08-18 |
| 2025-03-31 | $66.55K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $63.69K 10-K/A · filed 2026-08-14 |
| 2024-09-30 | $271.13K 10-Q · filed 2024-11-19 |
| 2024-06-30 | $33.99K 10-Q · filed 2024-08-19 |
| 2023-12-31 | $151.26K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |